FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:645-646 February 12, 2004 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

The recent cancellation of polio-vaccination campaigns in several key northern Nigerian states where poliomyelitis is endemic¹ has focused attention on this African country, which reported more cases of the disease in 2003 than any of the other six remaining countries with transmission of indigenous wild poliovirus. Nigeria is currently the country that poses the greatest risk to the achievement of the goal of eradicating poliomyelitis globally by the end of 2004. Although the current situation in Nigeria is of great concern, the country has already achieved remarkable progress toward eradication of the disease,² demonstrating its capacity to implement high-quality eradication . . . [Full Text of this Article]

Source Information

From the World Health Organization Office for Africa, Brazzaville, Republic of Congo (E.S.); the Noguchi Memorial Institute for Medical Research, University of Ghana Medical School, Legon, Ghana (F.N.); and the Department of Immunology and Microbiology, Faculty of Medicine, University of Yaoundé, Yaoundé, Cameroon (R.L.).

This article has been cited by other articles:

• Pallansch, M. A., Sandhu, H. S. (2006). The Eradication of Polio -- Progress and Challenges. NEJM 355: 2508-2511 [Full Text]  
• Aylward, R. B., Heymann, D. L. (2005). Can We Capitalize on the Virtues of Vaccines? Insights from the Polio Eradication Initiative. AJPH 95: 773-777 [Abstract] [Full Text]